Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 6 | 2025 | 952 | 1.400 |
Why?
|
| Mosaicism | 1 | 2024 | 480 | 0.730 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2024 | 594 | 0.710 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 757 | 0.470 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4912 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5432 | 0.250 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 13586 | 0.240 |
Why?
|
| Leukapheresis | 1 | 2025 | 150 | 0.230 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 66 | 0.230 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
| Microfluidics | 2 | 2025 | 672 | 0.170 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.170 |
Why?
|
| Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 2021 | 444 | 0.160 |
Why?
|
| Cell Count | 1 | 2022 | 1832 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 627 | 0.140 |
Why?
|
| Mitosis | 1 | 2021 | 1178 | 0.130 |
Why?
|
| Cell Separation | 1 | 2022 | 1728 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1885 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.120 |
Why?
|
| Stromal Cells | 1 | 2019 | 1336 | 0.110 |
Why?
|
| Prostatic Neoplasms | 3 | 2025 | 11101 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18349 | 0.080 |
Why?
|
| Mutation | 3 | 2024 | 30238 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 17140 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3912 | 0.070 |
Why?
|
| Genome, Human | 1 | 2020 | 4446 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10474 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3239 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 21206 | 0.060 |
Why?
|
| Estrogen Antagonists | 1 | 2023 | 151 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 18065 | 0.050 |
Why?
|
| Disease Progression | 1 | 2020 | 13671 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2021 | 23645 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2021 | 112 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2025 | 2540 | 0.050 |
Why?
|
| Aneuploidy | 1 | 2025 | 573 | 0.050 |
Why?
|
| Humans | 11 | 2025 | 768166 | 0.040 |
Why?
|
| Animals | 6 | 2023 | 169246 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3948 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 580 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2025 | 820 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 716 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 549 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 633 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 598 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1606 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2253 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8647 | 0.030 |
Why?
|
| Male | 5 | 2025 | 364719 | 0.030 |
Why?
|
| Female | 5 | 2025 | 397192 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6124 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1793 | 0.030 |
Why?
|
| Indoles | 1 | 2021 | 1836 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3611 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2062 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 6020 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2885 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 223492 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 3671 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4283 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 171504 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2059 | 0.020 |
Why?
|
| Mice | 3 | 2023 | 82029 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4146 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2846 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2019 | 4176 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5703 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19015 | 0.010 |
Why?
|
| Phenotype | 1 | 2023 | 16726 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11878 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20227 | 0.010 |
Why?
|
| Lung | 1 | 2020 | 10099 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13676 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41754 | 0.010 |
Why?
|
| Neoplasms | 1 | 2025 | 22371 | 0.010 |
Why?
|
Concepts
(83)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_